Drug Shortage Report for HP-PAC
| Report ID | 104791 |
| Drug Identification Number | 02238525 |
| Brand name | HP-PAC |
| Common or Proper name | AMOXICILLIN, LANSOPRAZOLE, CLARITHROMYCIN |
| Company Name | TAKEDA PHARMACEUTICALS AMERICA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN |
| Strength(s) | 500MG 30MG 500MG |
| Dosage form(s) | KIT CAPSULE TABLET CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL |
| Packaging size | HP PAC 7DAY THERAPY |
| ATC code | A02BD |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-01-24 |
| Estimated end date | Unknown |
| Actual end date | 2020-03-25 |
| Shortage status | Resolved |
| Updated date | 2020-03-26 |
| Company comments | product to be discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 95 HAYDEN AVENUE LEXINGTON, MASSACHUSETTS UNITED STATES 02421 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-03-26 | English | Compare |
| v4 | 2020-03-25 | French | Compare |
| v3 | 2020-03-25 | English | Compare |
| v2 | 2020-01-30 | French | Compare |
| v1 | 2020-01-30 | English | Compare |
Showing 1 to 5 of 5